News
Wedbush Maintains Outperform on Black Diamond Therapeutic, Raises Price Target to $16
8 Apr 24
News, Price Target, Analyst Ratings
Black Diamond Therapeutics Presented Novel Real-World Evidence Of The Evolving EGFR Mutation Landscape In NSCLC And The Opportunity For BDTX-1535 In An Oral Presentation At The 2024 AACR Annual Meeting
8 Apr 24
News
Wedbush Reiterates Outperform on Black Diamond Therapeutic, Maintains $10 Price Target
13 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Black Diamond Therapeutic: Q4 Earnings Insights
12 Mar 24
Earnings
Black Diamond Therapeutic Q4 EPS $(0.34) Beats $(0.47) Estimate; Cash, Cash Equivalents, And Investments Of $131.4M Expected To Be Sufficient To Fund Operations Into Q2 Of 2025
12 Mar 24
Earnings, News
Press releases
Garry Menzel joins GHO Capital as Operating Partner
23 Apr 24
Press Releases
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
7 Apr 24
Press Releases
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
3 Apr 24
News, Press Releases